We’ve approved N24bn waivers for 75 healthcare manufacturers to cut medical costs – Tinubu

President Bola Ahmed Tinubu has disclosed that the Federal Government approved more than N24 billion in tax and tariff waivers for 75 healthcare manufacturers between January 2025 and June 2026 as part of efforts to reduce Nigeria’s dependence on imported medicines and medical equipment.

The President also revealed that 10 factories for the production of essential healthcare products are being established across the country, including six in 2026, under his administration’s programme to transform the healthcare sector into a major contributor to economic growth, employment generation and improved medical services.

Tinubu, who made the disclosures in an opinion article titled ‘Why We Are Building Nigeria’s Healthcare Economy’, said the interventions were designed to strengthen domestic production, reduce the cost of essential medical supplies and reverse the growing dependence on foreign countries for specialist treatment.

He expressed concern that Nigeria, despite possessing an established pharmaceutical industry, highly skilled medical professionals and a large domestic market, continued to rely excessively on imported healthcare products.

According to him, the situation exposes Nigerian households to exchange rate fluctuations, disruptions in international supply chains and the enormous financial burden associated with medical tourism.

The President said his administration was determined to reverse the trend by ensuring that a greater proportion of Nigerians’ healthcare expenditure supports domestic industries, employment and specialist medical services.

He explained that the Executive Order he signed in June 2024 introduced tax and tariff relief for specified machinery, equipment and production inputs required by local healthcare manufacturers.

‘Between January 2025 and June 2026, the government approved more than N24 billion in waivers for 75 manufacturers. The purpose is to make investment and expansion more viable, with benefits that carry through to the availability and cost of essential products’, Tinubu stated.

The President said the intervention formed part of the Presidential Initiative for Unlocking the Healthcare Value Chain (PVAC), which he established in October 2023 to attract Nigerian and international investments into healthcare manufacturing and services.

He explained that the initiative was integrated into the Nigeria Health Sector Renewal Investment Initiative (NHSRII), launched in December 2023 to deliver the healthcare commitments of the Renewed Hope Agenda.

Tinubu said the framework brought together the Federal Government, states and development partners under a common reform programme aimed at strengthening healthcare governance, improving services, encouraging local production and enhancing preparedness for medical emergencies.

Giving details of the emerging investments, he disclosed that the 10 factories being established would produce medicines, diagnostic tests, medical oxygen, mosquito nets and other priority healthcare products.

He particularly highlighted developments in the local manufacturing of insecticide-treated mosquito nets, describing the emerging production capacity as an important breakthrough in Nigeria’s efforts to combat malaria while creating jobs.

According to him, following a 2024 agreement with PVAC, international healthcare manufacturer Vestergaard announced plans to commence operations at Health Textiles Nigeria in September 2026.

He added that Harvestfield, an indigenous company, was already producing dual-ingredient mosquito nets, while Nigerian workers were receiving specialised technical training in advanced manufacturing processes.

‘At full scale, the companies will produce more than ten million nets annually and employ more than 600 people’, the President said.

He noted that the investments would not only improve access to effective malaria prevention products but also support local suppliers, strengthen technical expertise and position Nigeria to serve other African markets.

Tinubu also cited progress in diagnostic manufacturing, particularly an agreement between Codix Bio and the Medicines Patent Pool, supported by the World Health Organisation, which provides for the transfer of technology from SD Biosensor to manufacture rapid diagnostic tests in Nigeria.

He identified NASENI-Troment as another company deploying advanced technology for the local production of diagnostic kits.

The President said such partnerships demonstrated the government’s determination to attract investments that would transfer technology, deepen local expertise and establish internationally competitive Nigerian healthcare enterprises.

‘Nigeria welcomes investors who bring capital, expertise, and a long-term commitment to production here.

‘Our market offers commercial opportunity with a strong, youthful demographic, and successful partnerships should leave the country with stronger businesses and deeper technical competence’, he stated.

Beyond manufacturing, Tinubu said his administration was also prioritising investments in advanced diagnostics, cancer treatment and other specialist medical services to reduce the number of Nigerians travelling abroad for healthcare.

He observed that medical tourism imposed additional financial and emotional burdens on families, particularly those requiring prolonged specialist treatment.

‘For a family facing cancer, access to treatment within Nigeria can spare them the added cost of travel abroad and long separation from loved ones’, he said.

The President, however, acknowledged that establishing factories and attracting investments would not automatically translate into cheaper medicines or improved healthcare access unless the government addressed persistent production costs and other structural challenges.

He said Nigerians would ultimately assess the success of the reforms by the quality, availability and affordability of healthcare services rather than the volume of announced investments.

‘I recognise that Nigerians will judge these reforms by the care they can obtain and afford today. New capacity takes time to reach its full effect.

‘Domestic manufacturers still face costs that we must address, and local production must meet demanding standards of quality and competitiveness. Government support must result in better products and affordable services for Nigerians’, he declared.

Tinubu explained that the administration was also strengthening the relationship between local manufacturers and healthcare facilities through improved purchasing arrangements.

He identified Medipool, Nigeria’s first nationally approved group purchasing organisation, as a major instrument for aggregating demand for quality medicines and other health commodities, negotiating better prices and providing a more reliable market for domestic manufacturers.

According to him, the arrangement would complement the expansion of primary healthcare through the Basic Health Care Provision Fund and ongoing efforts to widen health insurance coverage.

He said predictable orders from healthcare facilities would encourage further investments in local manufacturing while helping the government achieve better value for public expenditure.

The President emphasised that the benefits of the reforms must extend to rural communities through affordable treatment and reliable supplies of essential medicines and diagnostic products.

He consequently charged the Coordinating Minister of Health and Social Welfare to sustain collaboration with relevant government institutions and private sector partners to ensure that the investments deliver tangible results.

‘The next stage requires sustained attention to financing, reliable demand, and the practical conditions under which enterprises operate.

‘Announced investments must progress into production, and production must reach the facilities where Nigerians receive care. I expect the Coordinating Minister of Health and Social Welfare to sustain this work with the relevant institutions and private partners’, Tinubu said.

He maintained that strengthening Nigeria’s healthcare industry was essential to economic diversification, improved productivity and the development of human capital.

According to him, a healthier population would contribute more effectively to national development, while domestic healthcare manufacturing would create skilled employment, retain economic value within the country and generate opportunities for exports.

‘Nigeria’s healthcare needs should support a growing source of national prosperity. We can build businesses that serve our people, develop expertise that stays within our country and create products that compete beyond our borders.

‘The progress already made gives us a basis to pursue that ambition with confidence. Nigerians should expect these investments to deliver dependable care, more affordable treatment and opportunities to earn a decent living’, the President concluded.

Leave a Reply

Your email address will not be published. Required fields are marked *